Evidence of Extranuclear Cell Sensitivity to Alpha-Particle Radiation Using a Microdosimetric Model. II. Application of the Microdosimetric Model to Experimental Results

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Radiation Research

• Publication date

  2009-06-11

• Fields of study

  Medicine, Physics, Chemistry

• Identifiers
  DOI 10.1667/RR1536.1PMID 19580473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence of Extranuclear Cell Sensitivity to Alpha-Particle Radiation Using a Microdosimetric Model. I. Presentation and Validation of a Microdosimetric Model

  2009cited by this paper
• Cancer Stem Cell Targeting Using the Alpha-Particle Emitter, 213Bi: Mathematical Modeling and Feasibility Analysis

  2007cited by this paper
• The time and spatial effects of bystander response in mammalian cells induced by low dose radiation.

  2006cited by this paper
• In vitro cytotoxicity of 211At-labeled trastuzumab in human breast cancer cell lines: effect of specific activity and HER2 receptor heterogeneity on survival fraction.

  2006cited by this paper
• Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.

  2006influential reference
• Inhibitory and Stimulatory Bystander Effects are Differentially Induced by Iodine-125 and Iodine-123

  2006cited by this paper
• Radiobiologic principles in radionuclide therapy.

  2005cited by this paper
• Assessment of CD8 involvement in T cell clone avidity by direct measurement of HLA‐A2/Mage3 complex density using a high‐affinity TCR like monoclonal antibody

  2005cited by this paper
• Biological effects in unirradiated human tissue induced by radiation damage up to 1 mm away.

  2005cited by this paper
• Simulation of Binary Methods for the Microdosimetric Analysis of Cell Survival after Alpha-Particle Irradiation: Ability to Distinguish between Different Models

  2004cited by this paper
• Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study

  2004cited by this paper
• Binary Methods for the Microdosimetric Analysis of Cell Survival Data from Alpha-Particle Irradiation

  2003cited by this paper
• Biophysical model of the radiation-induced bystander effect

  2003cited by this paper
• The Cell Membrane as a Biosensor of Oxidative Stress Induced by Radiation Exposure: A Multiparameter Investigation

  2003cited by this paper
• Comparison of the biologic effects of MA5 and B‐B4 monoclonal antibody labeled with iodine‐131 and bismuth‐213 on multiple myeloma

  2002cited by this paper
• The Radiation-Induced Bystander Effect for Clonogenic Survival

  2002cited by this paper
• Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice

  2001cited by this paper
• Direct evidence for a bystander effect of ionizing radiation in primary human fibroblasts

  2001cited by this paper
• General aspects of the cellular response to low- and high-LET radiation

  2001cited by this paper
• The Bystander Effect in Radiation Oncogenesis: II. A Quantitative Model

  2001cited by this paper
• Induction of a bystander mutagenic effect of alpha particles in mammalian cells.

  2000cited by this paper
• Chromosomal instability in the descendants of unirradiated surviving cells after alpha-particle irradiation.

  1998cited by this paper
• Studies of bystander effects in human fibroblasts using a charged particle microbeam.

  1998cited by this paper
• The cytotoxicity and microdosimetry of astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro.

  1998cited by this paper
• Mutagenic effects of a single and an exact number of alpha particles in mammalian cells.

  1997cited by this paper
• Medium from irradiated human epithelial cells but not human fibroblasts reduces the clonogenic survival of unirradiated cells.

  1997cited by this paper
• Use of chord lengths through the nucleus to simulate the survival of mammalian cells exposed to high LET alpha-radiation.

  1996cited by this paper
• Alpha-particle-induced sister chromatid exchange in normal human lung fibroblasts: evidence for an extranuclear target.

  1996cited by this paper
• Analysis of survival of C-18 cells after irradiation in suspension with chelated and ionic bismuth-212 using microdosimetry.

  1994cited by this paper
• Alpha-particle-induced p53 protein expression in a rat lung epithelial cell strain.

  1994cited by this paper
• Microdosimetric concepts in radioimmunotherapy.

  1993cited by this paper
• Induction of sister chromatid exchanges by extremely low doses of alpha-particles.

  1992cited by this paper
• Radiobiology of α Particles: III. Cell Inactivation by α-Particle Traversals of the Cell Nucleus

  1991cited by this paper
• Radiobiology of alpha particles. III. Cell inactivation by alpha-particle traversals of the cell nucleus.

  1991cited by this paper
• A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy.

  1987cited by this paper
• The response of tumour cells to radiation and cytotoxic drugs--a comparison of clonogenic and isotope uptake assays.

  1984cited by this paper
• Microdosimetry of internal sources.

  1977cited by this paper
• Microdosimetry of internal sources. [/sup 239/Pu]

  1976cited by this paper
• Uptake and Incorporation of Tritiated Thymidine in in vitro Culture

  1961cited by this paper

• Targeted alpha therapy: a comprehensive analysis of the biological effects from “local-regional-systemic” dimensions

  2025cites this paper
• Evaluation the Effect of Chelating Arms and Carrier Agents in Radiotoxicity of TAT Agents.

  2022cites this paper
• Applying radiobiology to clinical molecular radiotherapy.

  2021cites this paper
• Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease

  2020cites this paper
• Advances in targeted alpha therapy for prostate cancer

  2019cites this paper
• Internal microdosimetry of alpha-emitting radionuclides

  2019cites this paper
• Radium-223 mechanism of action: implications for use in treatment combinations

  2019cites this paper
• Radionuclides in radiation-induced bystander effect; may it share in radionuclide therapy?

  2017cites this paper
• Principles of molecular targeting for radionuclide therapy

  2017cites this paper
• Cell irradiation dosimetry at the Portuguese Research Reactor in the frame of Boron Neutron Capture Therapy

  2016influential citation
• Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects

  2016cites this paper
• Realistic multi-cellular dosimetry for 177Lu-labelled antibodies: model and application

  2016cites this paper
• The cytoplasm as a radiation target: an in silico study of microbeam cell irradiation

  2015cites this paper
• Introduction to Radiobiology of Targeted Radionuclide Therapy

  2015cites this paper
• Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer

  2014cites this paper
• Dosimetry Methodology for Therapy End Points

  2014cites this paper
• DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy.

  2014cites this paper
• Dosimetry for radiopharmaceutical therapy.

  2014cites this paper
• Radiation damage on sub-cellular scales: beyond DNA

  2013cites this paper
• What is the Role of the Bystander Response in Radionuclide Therapies?

  2013cites this paper
• 213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

  2013cites this paper
• A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry

  2012cites this paper
• A bone marrow toxicity model for 223Ra alpha-emitter radiopharmaceutical therapy

  2012cites this paper
• Alpha-particle microdosimetry.

  2011cites this paper
• In vitro experimental 211At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin

  2010cites this paper